CL2008000139A1 - Modificacion de cristales de astaxantina; proceso de preparacion; formulacion que la comprende; proceso para producir la formulacion; y uso para la nutricion humana o animal. - Google Patents

Modificacion de cristales de astaxantina; proceso de preparacion; formulacion que la comprende; proceso para producir la formulacion; y uso para la nutricion humana o animal.

Info

Publication number
CL2008000139A1
CL2008000139A1 CL200800139A CL2008000139A CL2008000139A1 CL 2008000139 A1 CL2008000139 A1 CL 2008000139A1 CL 200800139 A CL200800139 A CL 200800139A CL 2008000139 A CL2008000139 A CL 2008000139A CL 2008000139 A1 CL2008000139 A1 CL 2008000139A1
Authority
CL
Chile
Prior art keywords
formulation
astaxantine
understands
crystals
modification
Prior art date
Application number
CL200800139A
Other languages
English (en)
Inventor
Jensen Jesper Feldthusen
Christian Kopsel
Helmut Auweter
Erik Luddecke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of CL2008000139A1 publication Critical patent/CL2008000139A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Insects & Arthropods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
CL200800139A 2007-01-19 2008-01-17 Modificacion de cristales de astaxantina; proceso de preparacion; formulacion que la comprende; proceso para producir la formulacion; y uso para la nutricion humana o animal. CL2008000139A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07100801 2007-01-19

Publications (1)

Publication Number Publication Date
CL2008000139A1 true CL2008000139A1 (es) 2008-05-23

Family

ID=39366121

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800139A CL2008000139A1 (es) 2007-01-19 2008-01-17 Modificacion de cristales de astaxantina; proceso de preparacion; formulacion que la comprende; proceso para producir la formulacion; y uso para la nutricion humana o animal.

Country Status (2)

Country Link
CL (1) CL2008000139A1 (es)
WO (1) WO2008087090A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE501644T1 (de) 2007-01-16 2011-04-15 Basf Se Flüssige formulierungen enthaltend carotinoide
CN105077203A (zh) 2007-11-29 2015-11-25 巴斯夫欧洲公司 用于饮料着色的粉状类胡萝卜素制剂
CA2720243A1 (en) * 2008-05-30 2009-12-03 Dsm Ip Assets B.V. Crystal forms of astaxanthin
EP2343986B2 (de) 2008-10-07 2021-04-21 Basf Se Gebrauchfertige, stabile emulsion
EP2792246A1 (de) 2013-04-17 2014-10-22 Basf Se Verfahren zur Herstellung einer Astaxanthin-Suspension
CN109965279A (zh) * 2013-11-07 2019-07-05 帝斯曼知识产权资产管理有限公司 包含合成的食品级虾青素的粉状制剂、油质悬浮物和膳食补充剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255206T3 (es) * 1998-08-05 2006-06-16 Dsm Ip Assets B.V. Preparacion de 4,4'-diceto-carotenoides.
CA2618447C (en) * 2005-08-15 2015-06-02 Phares Pharmaceutical Research N.V. Crystal forms of astaxanthin

Also Published As

Publication number Publication date
WO2008087090A1 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
CL2008001334A1 (es) Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer.
CL2009001484A1 (es) Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia.
CL2007002128A1 (es) Derivados de n'-ciano-n-halogenoalquil-imidamida; procedimiento para la preparacion de dicho compuesto; composiciones farmaceuticas que lo contienen; y uso del compuesto para combatir parasitos animales.
BRPI0913063A2 (pt) Compostos acilaminoácidos e preparações de alimentos que contém os mesmos
BRPI0821688A2 (pt) mistura para o tratamento de fertilizantes contendo uréia
CL2007003187A1 (es) Compuestos derivados de bencil-benzonitrilo sustituido con glucopiranosilo y sus sales; procedimiento de preparacion; compuestos intermediarios; proceso para preparar los compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de
CL2013001604A1 (es) Compuestos derivados de pirimidinona sustituida; composicion farmaceutica que los comprende; su uso para tratar la enfermedad de alzheimer y la aterosclerosis.
CL2013001282A1 (es) Sal succinato de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico; composicion farmaceutica que la comprende y procesos para su preparacion.
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
DK2227539T3 (da) Sammensætning til menneske- og/eller dyreernæring, anvendelser deraf og gær
BRPI0817812A2 (pt) Uso de anticorpos trkb para o tratamento de distúrbios respiratórios
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
BR112012016398A2 (pt) Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa
CR10406A (es) Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen
BRPI0820568A2 (pt) Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
BRPI0811871A2 (pt) Composições agroquímicas ácidas bioativas e uso das mesmas
CL2014002348A1 (es) Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
BRPI0917661A2 (pt) produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan
BRPI0819821A2 (pt) Preparação e uso de polianilinas para tratamento de água
CL2008000887A1 (es) Compuestos derivados de 3-hidroxi-1h-pirimidin-4-ona o 3-hidroxi-piran-4-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad neurodegenerativa causada por la presencia de
BRPI0908049A2 (pt) Uso de derivados de pririmidina para o tratamento de doenças dependentes de egfr ou de doenças que possuem resistência adquirida a agentes que são direcionados aos membros da família de egfr
BRPI0915439A2 (pt) composição tópica para o tratamento de ceratose actínica
LT2400943T (lt) Kosmetinė arba farmacinė emulsija odai, sumaišytina prieš pat naudojimą
BR112012001344A2 (pt) derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças
BRPI1009781A2 (pt) compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos